PGAM5 can inhibit BAX and cytochrome C-mediated apoptosis signal transduction by stabilizing Bcl-xl to obtain chemotherapy tolerance for HCC (Cheng et al., 2018). Here, BCL2L1 is linked to hepatocellular carcinoma.